Where the global cancer community meets - daily news, trial breakdowns. KOL interviews, live from major cancer congresses
OncoDaily - The Voice of Oncology
Why 1000 Doctors Gave This Cancer Drug A Standing Ovation? - Dr. Sandler shares how Revolution Medicines evolved from its early beginnings to becoming a leader in RAS-targeted therapies. He explains the scientific rationale behind targeting RAS-driven tumor.